Hypersensitivity to the active substance or to any of the excipients.
Concurrent or recent (i.e., within 2 weeks) therapy with a monoamine oxidase (MAO) inhibitor. At least 14 days should elapse between discontinuance of escitalopram and initiation of MAO inhibitor therapy and vice versa.
Concomitant use with pimozide.
Known hypersensitivity to escitalopram, citalopram.